Inspire Medical Systems (INSP) Free Cash Flow (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Free Cash Flow data on file, last reported at $9.9 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 165.27% year-over-year to $9.9 million; the trailing twelve-month figure through Mar 2026 stood at $103.4 million (up 42.47% YoY), and the FY2025 full-year result was $78.5 million, down 13.88% from the prior year.
• Free Cash Flow eased to $9.9 million in Q1 2026, from $41.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $62.2 million in Q4 2024 to a low of -$15.1 million in Q1 2025.
• A 5-year average of $11.9 million and a median of $6.2 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow jumped 1514.25% in 2022 and sank 544.15% in 2025, its largest moves.
• Tracing INSP's Free Cash Flow over 5 years: stood at $11.5 million in 2022, then jumped by 150.72% to $28.8 million in 2023, then soared by 115.48% to $62.2 million in 2024, then slumped by 32.73% to $41.8 million in 2025, then tumbled by 76.41% to $9.9 million in 2026.
• Business Quant data shows INSP's Free Cash Flow at $9.9 million in Q1 2026, $41.8 million in Q4 2025, and $46.5 million in Q3 2025.